1951 Stock Overview An investment holding company, provides assisted reproductive services (ARS) in China and the United States. More details
Rewards Risk Analysis No risks detected for 1951 from our risk checks.
See All Risk Checks Capture your thoughts, links and company narrative
Jinxin Fertility Group Limited Competitors Price History & Performance
Summary of share price highs, lows and changes for Jinxin Fertility Group Historical stock prices Current Share Price HK$2.81 52 Week High HK$4.64 52 Week Low HK$2.05 Beta 1.4 1 Month Change -4.42% 3 Month Change 23.79% 1 Year Change -12.19% 3 Year Change -68.28% 5 Year Change -74.13% Change since IPO -76.62%
Recent News & Updates
Investor sentiment deteriorates as stock falls 25% Oct 14
Investor sentiment improves as stock rises 18% Sep 25
First half 2024 earnings released: EPS: CN¥0.071 (vs CN¥0.084 in 1H 2023) Aug 31
Jinxin Fertility Group Limited to Report First Half, 2024 Results on Aug 29, 2024 Aug 09
Investor sentiment deteriorates as stock falls 18% Jul 25
Upcoming dividend of HK$0.059 per share Jun 20 See more updates
Investor sentiment deteriorates as stock falls 25% Oct 14
Investor sentiment improves as stock rises 18% Sep 25
First half 2024 earnings released: EPS: CN¥0.071 (vs CN¥0.084 in 1H 2023) Aug 31
Jinxin Fertility Group Limited to Report First Half, 2024 Results on Aug 29, 2024 Aug 09
Investor sentiment deteriorates as stock falls 18% Jul 25
Upcoming dividend of HK$0.059 per share Jun 20
Investor sentiment improves as stock rises 15% May 03
Full year 2023 earnings released: EPS: CN¥0.13 (vs CN¥0.049 in FY 2022) Apr 28
Jinxin Fertility Group Limited, Annual General Meeting, Jun 25, 2024 Mar 28
Full year 2023 earnings released: EPS: CN¥0.13 (vs CN¥0.049 in FY 2022) Mar 28
Jinxin Fertility Group Limited Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 25 July 2024 Mar 27
Jinxin Fertility Group Limited to Report Fiscal Year 2023 Results on Mar 27, 2024 Mar 13
Investor sentiment improves as stock rises 15% Feb 21
Non-Executive Director recently bought HK$2.0m worth of stock Jan 30
Co-CEO & Executive Director recently bought HK$3.6m worth of stock Jan 09
Investor sentiment deteriorates as stock falls 17% Jan 08
Jinxin Fertility Group Limited Announces Change of Chief Financial Officer Jan 02
First half 2023 earnings released: EPS: CN¥0.084 (vs CN¥0.076 in 1H 2022) Aug 31
Jinxin Fertility Group Limited to Report First Half, 2023 Results on Aug 29, 2023 Aug 09
Co-CEO & Executive Director recently bought HK$7.8m worth of stock Apr 04
Full year 2022 earnings released: EPS: CN¥0.049 (vs CN¥0.14 in FY 2021) Apr 01
Investor sentiment deteriorates as stock falls 18% Mar 09
Now 23% undervalued Feb 06 Jinxin Fertility Group Limited has completed a Follow-on Equity Offering in the amount of HKD 1.176875 billion. Jan 17
Investor sentiment improved over the past week Nov 30
Less than half of directors are independent Nov 16
Investor sentiment improved over the past week Nov 07
Chairman of the Board recently bought HK$6.5m worth of stock Oct 21
Investor sentiment improved over the past week Oct 19
Investor sentiment deteriorated over the past week Oct 04
First half 2022 earnings released: EPS: CN¥0.08 (vs CN¥0.063 in 1H 2021) Sep 02
Jinxin Fertility Group Limited to Report First Half, 2022 Results on Aug 31, 2022 Aug 20
Jinxin Fertility Group Limited Declares Final Dividend for the Year Ended December 31, 2021 Jun 29
Investor sentiment improved over the past week Jun 25
Upcoming dividend of HK$0.074 per share Jun 23
Investor sentiment improved over the past week Jun 01 Jinxin Fertility Group Limited, Annual General Meeting, Jun 28, 2022
CO-CEO & Executive Director recently bought HK$15m worth of stock May 13
Full year 2021 earnings released: EPS: CN¥0.14 (vs CN¥0.10 in FY 2020) Apr 30
Less than half of directors are independent Apr 27
Full year 2021 earnings released: EPS: CN¥0.14 (vs CN¥0.10 in FY 2020) Apr 01
Jinxin Fertility Group Limited Proposes Final Dividend for the Year Ended December 31, 2021, Payable on July 22, 2022 Mar 31
Investor sentiment deteriorated over the past week Mar 16
CEO & Executive Director recently bought HK$1.9m worth of stock Dec 10
CEO & Executive Director recently bought HK$1.0m worth of stock Nov 09
First half 2021 earnings released: EPS CN¥0.063 (vs CN¥0.048 in 1H 2020) Sep 03
Independent Non-Executive Director Haw Kuang Lim has left the company Sep 01
Joint Company Secretary Suet Wing Leung has left the company Aug 03
CEO & Executive Director recently bought HK$6.2m worth of stock Jul 29
Full year 2020 earnings released: EPS CN¥0.10 (vs CN¥0.19 in FY 2019) Apr 25
Chairman of the Board Bin Wang has left the company Mar 31
Full year 2020 earnings released: EPS CN¥0.10 (vs CN¥0.19 in FY 2019) Mar 29
Jinxin Fertility Group Limited to Report Q4, 2020 Results on Mar 28, 2021 Mar 17
New 90-day high: HK$19.40 Feb 06
New 90-day high: HK$17.22 Jan 22
New 90-day high: HK$15.80 Dec 31
New 90-day high: HK$15.04 Dec 16
Market bids up stock over the past week Nov 21
Market bids up stock over the past week Nov 19
Market bids up stock over the past week Nov 16
New 90-day high: HK$11.80 Nov 16
New 90-day low: HK$9.65 Oct 20
First half earnings released Sep 26
New 90-day low: HK$9.76 Sep 24
First half earnings released Sep 01
Jinxin Fertility Group Limited to Report First Half, 2020 Results on Aug 31, 2020 Aug 22
Jinxin Fertility Group Limited Announces Management Changes Jun 30 Shareholder Returns 1951 HK Healthcare HK Market 7D -7.6% -1.3% -0.5% 1Y -12.2% -17.8% 19.9%
See full shareholder returns
Return vs Market: 1951 underperformed the Hong Kong Market which returned 19.9% over the past year.
Price Volatility Is 1951's price volatile compared to industry and market? 1951 volatility 1951 Average Weekly Movement 13.0% Healthcare Industry Average Movement 8.3% Market Average Movement 8.8% 10% most volatile stocks in HK Market 18.6% 10% least volatile stocks in HK Market 4.1%
Stable Share Price: 1951 has not had significant price volatility in the past 3 months compared to the Hong Kong market.
Volatility Over Time: 1951's weekly volatility (13%) has been stable over the past year.
About the Company Jinxin Fertility Group Limited, an investment holding company, provides assisted reproductive services (ARS) in China and the United States. The company primarily offers two treatment solutions, including artificial insemination that is performed with either husband’s sperm or a donor sperm; and IVF technology, whereby fertilization is achieved through conventional in vitro fertilization and embryo transfer or IVF with intracytoplasmic sperm injection. It also provides related services, such as nutrition guidance, Chinese medicine treatment, and psychological counseling to support the ARS.
Show more Jinxin Fertility Group Limited Fundamentals Summary How do Jinxin Fertility Group's earnings and revenue compare to its market cap? 1951 fundamental statistics Market cap HK$7.71b Earnings (TTM ) HK$331.27m Revenue (TTM ) HK$3.09b
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) 1951 income statement (TTM ) Revenue CN¥2.90b Cost of Revenue CN¥1.70b Gross Profit CN¥1.19b Other Expenses CN¥883.30m Earnings CN¥310.84m
Last Reported Earnings
Jun 30, 2024
Earnings per share (EPS) 0.11 Gross Margin 41.19% Net Profit Margin 10.72% Debt/Equity Ratio 20.9%
How did 1951 perform over the long term?
See historical performance and comparison Dividends
2.0% Current Dividend Yield
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2024/12/22 09:38 End of Day Share Price 2024/12/20 00:00 Earnings 2024/06/30 Annual Earnings 2023/12/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources Jinxin Fertility Group Limited is covered by 30 analysts. 16 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution Sharon Shi BOCI Research Ltd. Ethan Cui BofA Global Research Qianyi Li China International Capital Corporation Limited
Show 27 more analysts 
